In a report released today, Matthew Weston from UBS upgraded AstraZeneca (AZN – Research Report) to a Buy, with a price target of £142.00. The ...

Results from a post-hoc exploratory subgroup analysis from the NIAGARA Phase III trial showed AstraZeneca’s (AZN) IMFINZI, administered perioperatively in combination with neoadjuvant ...

Learn More. AstraZeneca’s (LSE: AZN) share price remains significantly down from its 3 September 12-month traded high of £133.38. Such a drop could signal that the pharmaceuticals giant is ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

AstraZeneca may have exited the COVID-19 vaccine ... often do not respond adequately to vaccination alone and remain at high risk of serious outcomes from COVID-19. There is currently one antibody ...

After hours: February 14 at 7:52:35 PM EST Loading Chart for AZN ...

AstraZeneca's lengthy and turbulent development of CTLA4 inhibitor tremelimumab has at least led to a regulatory approval as part of a combination therapy for advanced liver cancer.

AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 18,745.88 Crore) operating in Pharmaceuticals sector. AstraZeneca Pharma India Ltd. key ...

House Republicans on Wednesday released their budget resolution in an effort to advance President Trump’s ambitious legislative agenda. Rep. Jodey Arrington (R-Texas), the chair of the House ...

The scenario is common. An elderly person seems to be in good health until one day they suffer a fall and from then on their quality of life begins to deteriorate.